InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.33
(
0.48%
)
Bitcoin
58,248.16
(
-3.18%
)
Post# of 252484
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

semi_infinite

Send PM Follow Ignore
Followers 14
Posts 3822
Boards Moderated 1
Alias Born 07/07/2002

semi_infinite

Re: semi_infinite post# 252014

Wednesday, 06/05/2024 3:33:22 PM

Wednesday, June 05, 2024 3:33:22 PM

Post# of 252484
sfmd - q1 update scheduled for 6/12 pre-market. IMO they provide update on afm13-203 run in NK doses and folks will be interested in whether they can repeat the success of MDACC's afm13-104 and the more involved cbNK cell processing used by MDACC.

https://www.affimed.com/affimed-announces-oral-presentation-of-phase-1-2-data-from-afm13-in-combination-with-allogeneic-nk-cells-at-the-2023-ash-annual-meeting/
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up